“…The pyridine dicarbonitrile substructure was therefore chosen as a basic structural scaffold for the design of a reaction-based library (Reddy et al, 2006). Many publications report the biological properties of pyridinedicarbonitriles as being antihypertensive (Ward, 1976), antihistaminic (Quintela et al, 1997), anticancer, (Cocco et al, 2007) anti-inflammatory, analgesic (Manna et al, 1992), antibacterial (Behbehani et al, 2012), anti-HIV agents (El-Hawash et al, 2006) and anti-Alzheimer (Samadi et al, 2010). Many derivatives of pyridine-3,5-dicarbonitrile are reported as potential therapeutic agents, In hope to discover novel therapeutic agents, a series of 6-amino-1-(5, 6-dimethoxy-2,3-dihydro-1H-inden-1-ylideneamino)-2-oxo-4-aryl-1,2-dihydropyridine-3,5-dicarbonitrile compound are prepared which have not been reported before and compounds are tested for their antibacterial and antifungal activities.…”